Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists

被引：7

作者：

Troxler, Thomas ^{[1
]}

Hoyer, Daniel ^{[1
]}

Langenegger, Daniel ^{[1
]}

Neumann, Peter ^{[1
]}

Pfaeffli, Paul ^{[1
]}

Sehoeffter, Philippe ^{[1
]}

Sorg, Dieter ^{[1
]}

Swoboda, Robert ^{[1
]}

Hurth, Konstanze ^{[1
]}

机构：

[1] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 14期

关键词：

somatostatin sst(1) receptor antagonists; octa-hydrobenzo[g]quinolines (obelines);

D O I：

10.1016/j.bmcl.2007.04.086

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A novel class of non-peptide somatostatin receptor ligands bearing the octahydrobenzo[g]quinoline (obeline) structural element has been identified. SAR studies have been performed that led to the discovery of derivatives with high affinity (pK(d) r sst(I) >= 9) and selectivity (>= 150-fold for h sst(1) over h sst(2)-h sst(5)) for somatostatin receptor subtype sst(1). In a functional assay, the compounds act as antagonists at human recombinant sst, receptors. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：3983 / 3987

页数：5

共 50 条

[31] Identification of potent, selective and metabolically stable CGRP receptor peptide antagonists
Shi, L.
Gegg, C., V
Wright, M.
Miranda, L. P.
Holder, J. R.
Zhu, D.
Aral, J.
Doellgast, G.
Rogers, R.
Li, H.
Salyers, K.
Dong, H.
Manning, B.
Johnson, E.
Xu, C.
Wild, K.
CEPHALALGIA, 2009, 29 : 139 - 139
[32] Different Pathways of Internalization of the Somatostatin Receptor sst3 and the Possible Autoreceptor sst1
Dirk Roosterman
Paul A Stevens
Wolfgang Meyerhof
Pediatric Research, 1999, 45 : 97 - 97
[33] Different pathways of internalization of the somatostatin receptor sst3 and the possible autoreceptor sst1
Roosterman, D
Stevens, PA
Meyerhof, W
PEDIATRIC RESEARCH, 1999, 45 (04) : 97A - 97A
[34] APPLICATION OF THE MESSAGE ADDRESS CONCEPT IN THE DESIGN OF HIGHLY POTENT AND SELECTIVE NON-PEPTIDE DELTA-OPIOID RECEPTOR ANTAGONISTS
PORTOGHESE, PS
SULTANA, M
NAGASE, H
TAKEMORI, AE
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (02) : 281 - 282
[35] CP-154.526: A potent and selective non-peptide antagonist of the CRF receptor
Chen, YL
Braselton, J
Collins, J
Costello, D
Corman, M
Dunaiskis, A
Faraci, S
Heym, J
Mansbach, R
Schmidt, A
Schulz, D
Seeger, T
Sprouse, J
Tingley, D
Winston, E
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 212 : 195 - MEDI
[36] The design and synthesis of non-peptide somatostatin receptor agonists
Yang, LH
Pan, YP
Guo, LQ
Morriello, G
Pasternak, A
Rohrer, S
Schaeffer, J
Patchett, AA
PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 250 - 252
[37] Discovery of novel non-peptide CCR1 receptor antagonists
Ng, HP
May, K
Bauman, JG
Ghannam, A
Islam, I
Liang, M
Horuk, R
Hesselgesser, J
Snider, RM
Perez, HD
Morrissey, MM
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (22) : 4680 - 4694
[38] Discovery of a novel non-peptide somatostatin agonist with SST4 selectivity
Ankersen, M
Crider, M
Liu, SQ
Ho, B
Andersen, HS
Stidsen, C
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1998, 120 (07) : 1368 - 1373
[39] Non-peptide angiotensin type 1 receptor antagonists in the treatment of hypertension
Birkenhäger, WH
de Leeuw, PW
JOURNAL OF HYPERTENSION, 1999, 17 (07) : 873 - 881
[40] Process development of AAE421:: A somatostatin sst1 receptor antagonist
Lu, Yansong J.
Hu, Bin
Prashad, Mahavir
Repie, Olan
Blacklock, Thomas J.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U3342 - U3343

← 1 2 3 4 5 →